There is no word yet on when the IPO will happen. According to Voyager, it is still working out "the number of shares to be ...
Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...
A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...